Sign in

NCT06120764Recruiting

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting

Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting in Pediatric Oncology Patients: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
2 Nov 2023
Start date
10 Nov 2023
Primary completion date
30 Sept 2026
Lead sponsor
Baskent University
NCT number
NCT06120764

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 10 Nov 2023 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Children receiving radiotherapy,

Other

  • taking ginger powder or vitamins to reduce nausea,
  • children who did not want to participate in the study

Who the study is looking for

  • 7 to 18 years old,
  • who will receive intravenous chemotherapy,
  • no cognitive or neurological disease that would prevent communication,
  • receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
  • no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
  • children whose parents and themselves volunteered to participate in the study

Age in the registry: 7 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Hacettepe University İhsan Doğramacı Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.